PDF电子书：LIPOPROTEINS – ROLE IN HEALTH AND DISEASES （2012）

xyklmu

7 d2 n: }2 E# w8 T7 T
3 ]/ w' r" C* z+ W  b[hide][/hide]8 q/ a6 e3 z9 w4 f
LIPOPROTEINS – ROLE IN HEALTH AND DISEASES' _! I- t  v( d9 ^, ~1 p
Edited by Saša Frank and Gerhard Kostner
5 {6 @- k- d3 |" B+ t2 y
9 k+ G; |0 ?+ G* S+ E共28章 774页
& q' v- Q) Q+ ?& g. ]* N" [. \& h* O: _1 z* u6 p0 h  u- I

( a2 ?3 x7 {8 r8 B+ HContents
- |: }/ q: m) S, M$ QPreface XI
! C4 k3 G1 E, `5 `! @Section 1 Lipoprotein Structure and Assembly 18 `, c0 r5 J, z5 P' h0 ?( z! s
Chapter 1 Lipoprotein Structure and Dynamics: Low Density Lipoprotein Viewed as a Highly Dynamic and Flexible Nanoparticle 3- o5 `: C7 g$ f/ L! v
Ruth Prassl and Peter Laggner8 m  T0 ^1 X5 H# c: P  R1 r
Chapter 2 New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins
5 e6 o5 T  C5 U+ }# {from in vivo Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease 21+ Z$ t- _" c3 H4 o
Benjamin Dieplinger and Hans Dieplinger
7 q9 L3 h/ [$ ?3 c. ASection 2 Diagnosis of Lipoprotein Disorders 45. f$ N6 ^1 x* J, l! U" V* b
Chapter 3 The Importance of Lipid and Lipoprote in Ratios in Interpretetions of Hyperlipidaemia of Pregnancy 47( {6 _) Z, u, i9 W3 e' f
D.S. Mshelia and A.A. Kullima
9 J& x) J7 e7 J9 P* K% SChapter 4 A Non-Atherogenic and Atherogenic Lipoprotein Profile in Individuals with Dyslipoproteinemia 734 H9 S4 y  @3 s5 G
Stanislav Oravec, Johannes Mikl,
5 _9 ], s9 c% N) ?( X5 X5 OKristina Gruber and Elisabeth Dostal, O5 x: \% C- g2 B$ C$ O4 j) P6 S
Chapter 5 The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk 95" H: d2 R- o, V; Q7 {5 H* z
Göran Walldius
  N1 _. O: m: i  P. s1 uChapter 6 Approaches to Access Biological Data Sources 149
, t' f8 A1 q4 X* W4 I$ N7 d* JAssia Rharbi, Khadija Amine, Zohra Bakkoury,8 Y" [, B2 b( q4 ^/ n' [
Afaf Mikou, Anass Kettani andAbdelkader Betari
4 g( O1 {2 C* e. RVI Contents( Y) `9 h) V; Y* d& T0 S  B2 G
Section 3 Hyper- and Dyslipoproteinemias 1717 v; S) g2 [: j. L
Chapter 7 Lipoproteins Impact Increasing Cardiovascular Mortality 173, `; D( J# T, m( `1 n, ~: t
Jelena Umbrasiene, Ruta-Marija Babarskiene and Jone Vencloviene' I" M3 K) U1 |7 I+ l( C: V( S& A
Chapter 8 Lipoproteins and Cardiovascular Diseases 197$ a/ t) U: w1 B
Adebowale Saba and Olayinka Oridupa
, W+ @- {# \4 J) N2 G& ]Chapter 9 Linking the Pathobiology of Hypercholesterolemia with the Neutrophil Mechanotransduction 223
2 c" g4 I) m& {! |; Z/ C, i- r1 i9 XXiaoyan Zhang and Hainsworth Y. Shin, P% P! d% j! z1 J8 C2 R
Section 4 Management of Hyper and Dyslipoproteinemias 253% c" q% e) r, R  g9 N, R
Chapter 10 The Confounding Factor of Apolipoprotein E on Response to Chemotherapy and Hormone Regulation Altering Long-Term Cognition Outcomes 255
$ \7 m; X$ S: p/ Q: n. mSummer F. Acevedo
8 Q. U' d: t/ X/ dChapter 11 Anticholesterolemic and Antiatherogenic Effects of Taurine Supplementation is Model Dependent 269, K! Z+ I6 m0 M( o( U. V
Karl-Erik Eilertsen, Rune Larsen, Hanne K. Mæhre, Ida-Johanne Jensen and Edel O. Elvevoll
; K+ h- z% v5 W! d/ C) kChapter 12 Endoscopic Treatment of Metabolic Syndrome 289: `: @5 ]3 u# Z3 K, Y8 V2 f
Eduardo Guimarães Hourneaux de Moura, Ivan Roberto Bonotto
8 u6 X# G9 v# P0 k" zOrso, Bruno da Costa Martins and Guilherme Sauniti Lopes
' f3 ]4 D4 s  d7 E- i; w9 S# tChapter 13 Nutritional Management of Disturbances in Lipoprotein Concentrations 3034 F& o4 l1 g& P1 I, p% g( H- P
Somayeh Hosseinpour-Niazi, Parvin Mirmiran and Fereidoun Azizi* V- x/ p0 [# g
Chapter 14 Cyclosporin A-Induced Hyperlipidemia 337
4 Z/ Y* e& w( G3 Z2 w6 y. I0 k2 C9 tMaaike Kockx and Leonard Kritharides
1 S: [/ j9 B0 f6 s, {/ nChapter 15 Lipoproteins and Apolipoproteins of the Ageing Eye 355: ?1 ?2 q6 ^5 U3 {
Edward Loane
; R7 n7 f  P, E; U# HSection 5 Lipid Oxidation and Anti-Oxidants 381
) \# }1 R: q; F* @* z' S" aChapter 16 Pathophysiology of Lipoprotein Oxidation 383
+ {  U# i1 P# E0 g2 P7 ~6 iVikram Jairam, Koji Uchida and Vasanthy Narayanaswami
) \5 h1 g9 U: W1 S0 OChapter 17 Oxidized Phospholipids: Introduction and Biological Significance 409
7 L0 e& Y4 F2 V( I5 uMohammad Z. Ashraf and Swati Srivastava
" X. i" ?1 h% a0 mContents VII) C3 [1 {- U  t9 A$ D- B
Chapter 18 HDL-Associated Paraoxonase 1 Gene Polymorphisms as a Genetic Markers for Wide Spread Diseases 431' {! Z- b; n5 U/ @6 v! A1 \
Ivana Pejin-Grubiša
1 K! `0 `$ X" C9 DChapter 19 Antioxidant Complexes and Lipoprotein Metabolism – Experience of Grape Extracts Application Under Metabolic Syndrome and Neurogenic Stress 445/ {. J6 p% K) q( ?; b
Andriy L. Zagayko, Anna B. Kravchenko,
7 h% }6 s' d9 r8 Z% N5 J7 fMykhaylo V. Voloshchenko and Oxana A. Krasilnikova
" [4 M" `4 O: p7 bChapter 20 The Anti-Atherogenic Effects of Lycopene 489
5 O5 q) Z8 c1 i" k0 KAmany M. M. Basuny  I, `% F' u6 C6 O4 I
Section 6 Animal Models for Lipoprotein Research 507
) x3 m& ]# n6 v% K  }- r2 YChapter 21 Animal Models as Tools for Translational Research: Focus on Atherosclerosis, Metabolic Syndrome and Type-II Diabetes Mellitus 5090 u) J- j" M6 k2 a6 w8 f
Isaac Karimi* T4 I& r+ r9 Q* O6 {
Chapter 22 Genetically Modified Animal Models for Lipoprotein Research 5336 P# E+ h3 h* ^0 n3 X5 s. N; k
Masashi Shiomi, Tomonari Koike and Tatsuro Ishida
' l* Y0 o6 o& g0 lSection 7 Role of Lipoproteins in Neurodegenerative Diseases 5619 v# i2 k, U7 k0 S
Chapter 23 Plasma Lipoproteins in Brain Inflammatory and Neurodegenerative Diseases 563
! |$ S7 }' F2 rArmando Sena, Carlos Capela, Camila Nóbrega,
! k  L6 Y0 N1 A1 f0 B7 R/ XVéronique Férret-Sena, Elisa Campos and Rui Pedrosa
7 K; s. y6 h7 J9 aChapter 24 Genetics of Ischemic Stroke: Emphasis on Candidate-Gene Association Studies 583
# S5 I3 H# e: C) wSanja Stankovic, Milika Asanin and Nada Majkic-Singh
2 n2 ~+ W; j/ q2 tChapter 25 Lipoproteins and Apolipoproteins in Alzheimer's Disease 6133 r4 D$ l0 @/ Z0 x+ d
Etsuro Matsubara
" M( e. m2 e+ O( L0 ^6 _+ U3 P* oSection 8 Lipoproteins and Cancer 621
) J5 S3 X/ e* v) ?Chapter 26 Lipoproteins and Cancer 623+ _7 U: F( {4 [/ R- J; p
Caryl J. Antalis and Kimberly K. Buhman
  b: o+ \. t3 X, S& \Chapter 27 Role of Lipoproteins in Carcinogenesis and in Chemoprevention 647
- I# n# R% k! @Adebowale Bernard Saba and Temitayo Ajibade

s06806

我又回复了  

tuanzi

HOHO~~~~~~  

marysyq

好 好帖 很好帖 确实好帖 少见的好帖  

sky蓝

我等你哟!  

foxok

HOHO~~~~~~  

陈晴

我有家的感觉~~你知道吗  

我心飞翔

应该加分  

foxok

站个位在说  

aakkaa

支持~~